TAXILAN

उत्पाद अवलोकन

About TAXILAN

TAXILAN is a medication containing the active ingredient Paclitaxel, classified as Microtubule Inhibitor. Paclitaxel, sold under the brand name Taxol among others, is a chemotherapy medication used to treat ovarian cancer, esophageal cancer, breast cancer, lung cancer, Kaposi's sarcoma, cervical cancer, and pancreatic cancer. It is administered by intravenous injection. There is also an albumin-bound formulation.

Key Benefits & Uses

• Used for: INDICATIONS AND USAGE Paclitaxel Injection, USP is indicated as subsequent therapy for the treatment of advanced carcinoma of the ovary
• Used for: As first-line therapy, Paclitaxel Injection, USP is indicated in combination with cisplatin
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Paclitaxel, the active ingredient in TAXILAN, belongs to the Microtubule Inhibitor class. INDICATIONS AND USAGE Paclitaxel Injection, USP is indicated as subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, Paclitaxel Injection, USP is indicated in combination with cisplatin. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking TAXILAN. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use TAXILAN for extended periods without medical advice.